Soligenix Inc (SNGX) Actualités

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma PR...

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease PR...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results PR Newswire PRINCETON...

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

PRINCETON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the...

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin PR Newswire PRINCETON...

Soligenix Invited to Present at Upcoming Investor Conferences

Soligenix Invited to Present at Upcoming Investor Conferences PR Newswire PRINCETON, N.J., Oct. 16, 2024...

Form 8-K - Current report

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of...

Soligenix Announces Partnership with Sterling Pharma Solutions

Soligenix Announces Partnership with Sterling Pharma Solutions PR Newswire PRINCETON, N.J., Oct. 3, 2024 U.S...

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024 PR...

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin PR Newswire PRINCETON, N.J...